Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency

J Thromb Haemost. 2013 Mar;11(3):474-80. doi: 10.1111/jth.12106.

Abstract

Background: Post-thrombotic syndrome (PTS) is the most frequent complication of deep vein thrombosis (DVT). Its diagnosis is based on clinical characteristics. However, symptoms and signs of PTS are non-specific, and could result from concomitant primary venous insufficiency (PVI) rather than DVT. This could bias evaluation of PTS.

Methods: Using data from the REVERSE multicenter study, we assessed risk factors for PTS in patients with a first unprovoked unilateral proximal DVT 5-7 months earlier who were free of clinically significant PVI (defined as absence of moderate or severe venous ectasia in the contralateral leg).

Results: Among the 328 patients considered, the prevalence of PTS was 27.1%. Obesity (odds ratio [OR] 2.6 [95% confidence interval (CI) 1.5-4.7]), mild contralateral venous ectasia (OR 2.2 [95% CI 1.1-4.3]), poor International Normalized Ratio (INR) control (OR per additional 1% of time with INR < 2 during anticoagulant treatment of 1.018 [95% CI 1.003-1.034]) and the presence of residual venous obstruction on ultrasound (OR 2.1 [95% CI 1.1-3.7]) significantly increased the risk for PTS in multivariable analyses. When we restricted our analysis to patients without any signs, even mild, of contralateral venous insufficiency (n = 244), the prevalence of PTS decreased slightly to 24.6%. Only obesity remained an independent predictor of PTS (OR 2.6 [95% CI 1.3-5.0]). Poor INR control and residual venous obstruction also increased the risk, but the results were no longer statistically significant (OR 1.017 [95% CI 0.999-1.035] and OR 1.7 [95% CI 0.9-3.3], respectively).

Conclusions: After a first unprovoked proximal DVT, obese patients and patients with even mild PVI constitute a group at increased risk of developing PTS for whom particular attention should be paid with respect to PTS prevention. Careful monitoring of anticoagulant treatment may prevent PTS.

Trial registration: ClinicalTrials.gov NCT00261014.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / therapeutic use
  • Canada / epidemiology
  • Dilatation, Pathologic
  • Drug Monitoring / methods
  • Europe / epidemiology
  • Female
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Obesity / epidemiology
  • Odds Ratio
  • Postthrombotic Syndrome / diagnosis
  • Postthrombotic Syndrome / drug therapy
  • Postthrombotic Syndrome / epidemiology*
  • Predictive Value of Tests
  • Prevalence
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • United States / epidemiology
  • Veins / pathology
  • Venous Insufficiency / epidemiology*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / epidemiology*

Substances

  • Anticoagulants

Associated data

  • ClinicalTrials.gov/NCT00261014